# Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis

> **NCT03594487** · PHASE1 · TERMINATED · sponsor: **Jeffrey Gelfand** · enrollment: 5 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** FMP30 Donor Stool
- **PROCEDURE:** Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool
- **OTHER:** Observational Control

## Key facts

- **NCT ID:** NCT03594487
- **Lead sponsor:** Jeffrey Gelfand
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-16
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Under-enrollment, including after interruption due to a hold on source FMT material and the COVID-19 pandemic
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594487, "Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03594487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*